MedPath

The SYMPTOM Study: factors influencing patient appraisal of symptoms

Not Applicable
Completed
Conditions
Topic: National Cancer Research Network, Primary Care Research Network for England
Subtopic: Colorectal Cancer, Upper Gastro-Intestinal Cancer, Lung Cancer, Not Assigned
Disease: Colon, Lung (small cell), Lung (non-small cell), Pancreas, Rectum, All Diseases
Cancer
Registration Number
ISRCTN47493581
Lead Sponsor
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge (UK)
Brief Summary

2014 results in: https://www.ncbi.nlm.nih.gov/pubmed/25553249 2015 results in: https://www.ncbi.nlm.nih.gov/pubmed/25734397 2015 results in: https://www.ncbi.nlm.nih.gov/pubmed/26453591 2016 results in: https://www.ncbi.nlm.nih.gov/pubmed/27490803 2016 results in: https://www.ncbi.nlm.nih.gov/pubmed/28404200 2017 results in: https://www.ncbi.nlm.nih.gov/pubmed/28871013

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
7000
Inclusion Criteria

Respiratory symptoms:
1. Aged over 40 years, either sex
2. Persistent or changed cough
3. Change of breathlessness
4. Chest pain (intermittent, worse when breathing or coughing)
5. Coughing up blood-stained phlegm (haemoptysis)
6. GP expressed concern about possibility of cancer

Gastrointestinal symptoms:
1. Aged over 40 years, either sex
2. Change in bowel habit
3. Blood in stool
4. Abdominal pain with weight loss
5. Abdominal mass
6. Anaemia
7. GP expressed concern about possibility of cancer

Exclusion Criteria

Respiratory symptoms:
1. Review of established diagnosis where there is no cancer concern
2. Previous lung or ENT cancer

Gastrointestinal symptoms:
1. Review of established diagnosis where there is no cancer concern
2. Previous gastrointestinal (GI) cancer
3. Chronic alcohol abuse (to exclude chronic pancreatitis)
4. Known infective diarrhoea (e.g., after recent foreign travel)
5. Abdominal pain in the absence of weight loss
6. Dyspepsia
7. Upper abdominal pain where dyspepsia is a significant symptom

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Identification of patient and symptom factors associated with later presentation to health care, measured at 24 months (end of study)
Secondary Outcome Measures
NameTimeMethod
<br> 1. Association of delay in presentation of symptoms with stage at diagnosis, measured at 24 months (end of study)<br> 2. Understanding patient interpretation of symptoms and the language used by patients, measured at 24 months (end of study)<br>
© Copyright 2025. All Rights Reserved by MedPath